<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR15">
 <label>15.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Reck</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>von Pawel</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Zatloukal</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Ramlau</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Gorbounova</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Hirsh</surname>
    <given-names>V</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAiL</article-title>
  <source>J Clin Oncol</source>
  <year>2009</year>
  <volume>27</volume>
  <fpage>1227</fpage>
  <lpage>1234</lpage>
  <pub-id pub-id-type="doi">10.1200/JCO.2007.14.5466</pub-id>
  <?supplied-pmid 19188680?>
  <pub-id pub-id-type="pmid">19188680</pub-id>
 </element-citation>
</ref>
